Cargando…
Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
Cell surface glycosylation is dynamic and often changes in response to cellular differentiation under physiological or pathophysiological conditions. Altered glycosylation on cancers cells is gaining attention due its wide-spread occurrence across a variety of cancer types and recent studies that ha...
Autores principales: | Rodrigues, Emily, Macauley, Matthew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025361/ https://www.ncbi.nlm.nih.gov/pubmed/29912148 http://dx.doi.org/10.3390/cancers10060207 |
Ejemplares similares
-
Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype
por: Beatson, Richard, et al.
Publicado: (2020) -
C-Myc-induced hypersialylation of small cell lung cancer facilitates pro-tumoral phenotypes of macrophages
por: Tian, Lin, et al.
Publicado: (2023) -
BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
por: Shu, Xiaodong, et al.
Publicado: (2023) -
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
por: Bordron, Anne, et al.
Publicado: (2018) -
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
por: Daly, John, et al.
Publicado: (2022)